Govt sees Covaxin efficacy as validation of its scientific process
The phase 3 results of Covaxin released on Wednesday showing 81% efficacy is seen by the government as a major validation of the scientific process and regulatory decision making while granting emergency use authorisation that helped in achieving a timely rollout of the nationwide vaccination programme on January 16.
💡 newsR Knowledge: Other News Mentions
Govt claims contrary to reality: ChidambaramCongress leader P. Chidambaram on Sunday lashed out at the government for making claims 'contrary to the reality' in the country.
Govt denies it is planning to scale back rapid COVID testing amid concerns over false positivesThe government has denied it is planning to scale back rapid coronavirus testing after reports claimed senior officials are concerned about false positives.
MP queries lack of BSL interpreter at Downing Street press conferences
Credit: PA - Press Association STUDIO Duration: 00:45Published
Section 144 in Maharashtra: What's open, what's not
Credit: ANI Duration: 02:13Published
Use entire national capacity to step up Covid vaccine production, PM tells officialsThe PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
Covaxin production to be increased to 100 million doses per month by September 2021: CentreUnion health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
India to increase Covaxin production to 100 million doses per month by SeptemberThe Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin
Credit: ANI Duration: 01:14Published
You Might Like
Related news from verified sources